L1 Capital International Strategy Trimmed HCA Healthcare (HCA) Due to Share Price Appreciation
L1 Capital, an investment management firm, released its “L1 Capital International Fund” (unhedged) fourth-quarter 2025 investor letter. A copy of...
L1 Capital, an investment management firm, released its “L1 Capital International Fund” (unhedged) fourth-quarter 2025 investor letter. A copy of...
PRESS RELEASEPublished January 10, 2026The global biotechnology industry is entering a period of rapid growth. Aurum Capital has launched the...
NEW YORK--(BUSINESS WIRE)--Jan 7, 2026-- Catalio Capital Management, LP (“Catalio”), a leading innovative healthcare investment firm, today announced the successful...
– RA Capital and OMERS Life Sciences provide up to $250 million loan facility to commercial-stage biopharma company ARS Pharma...
– RA Capital and OMERS Life Sciences provide up to $250 million loan facility to commercial-stage biopharma company ARS Pharma...
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look...
Continues Successful Strategy of Discovering and Investing in Breakthrough Biomedical Technologies Around the Globe NEW YORK, July 01, 2025--(BUSINESS WIRE)--Catalio...
When it comes to investing, there are some useful financial metrics that can warn us when a business is potentially...
If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world,...